CTNNB1 and central nervous system cancer: Among those lncRNAs, MIR22HG shows that glioma progression can be inhibited by downregulation of micNA-9/CPEB3 (20) and inhibits glioblastoma progression through Wnt/beta-catenin signaling (21).